The Scientist

» ebola and evolution

Most Recent

image: Unraveling H7N9’s History

Unraveling H7N9’s History

By | December 30, 2014

An analysis of stored samples shows that H7N9 precursor H9N2, a virus widespread in chickens, has shown increased fitness in recent years.

0 Comments

image: Bats the Source of Ebola?

Bats the Source of Ebola?

By | December 30, 2014

The epidemic in West Africa may have been sparked by bats in Guinea, researchers propose, but concrete evidence of the route of zoonotic infection is lacking.

2 Comments

image: CDC Tech Exposed to Ebola?

CDC Tech Exposed to Ebola?

By | December 29, 2014

A Centers for Disease Control and Prevention lab mistakenly transferred the wrong Ebola samples—ones that may have contained live virus—to another agency lab.

1 Comment

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

0 Comments

image: Science Setbacks: 2014

Science Setbacks: 2014

By | December 25, 2014

This year in life science was marked by paltry federal funding increases, revelations of sequence contamination, and onerous regulations.

0 Comments

image: Behavior Brief

Behavior Brief

By | December 18, 2014

A round-up of recent discoveries in behavior research

0 Comments

image: Ebola Update

Ebola Update

By | December 17, 2014

Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics

0 Comments

image: Mining Existing Drugs for Ebola Treatments

Mining Existing Drugs for Ebola Treatments

By | December 17, 2014

Researchers hope to repurpose already-approved drugs into potential anti-Ebola therapies.

0 Comments

image: Iron-Ferrying Protein Impedes Pathogens

Iron-Ferrying Protein Impedes Pathogens

By | December 15, 2014

Meningitis-causing bacteria exerted strong evolutionary pressure on an iron-binding protein in primates, a study shows.

0 Comments

image: Ebola Update

Ebola Update

By | December 11, 2014

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham